Skip to main content
Signal8

JEFFS ROGER

SEC insider (Form 3/4/5 filer). CIK 0001231615. Chief Executive Officer at Liquidia Corp (LQDA) and 1 other issuer. 59 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in MORRISVILLE, NC.

Companies JEFFS ROGER has filed insider reports for

  • Liquidia Corp (LQDA): Director, Officer, Chief Executive Officer
  • Axsome Therapeutics, Inc. (AXSM): Director
JEFFS ROGER profile photo

JEFFS ROGER

CIK: 0001231615

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)41 (69.5%)

Position reduction

Option Exercises (M)12 (20.3%)

Derivative conversions

Awards (A)6 (10.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Liquidia Corp logo
LQDA

Liquidia Corp

DirectorOfficer
Axsome Therapeutics, Inc. logo
AXSM

Axsome Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (59 total)

  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Oct 12, 2026
    Sale
    Direct
    32.7K shares at avg. $28.48$933K
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Oct 9, 2026
    Exercise
    Direct
    14.3K shares-
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Oct 9, 2026
    Exercise
    Direct
    13.8K shares-
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Jul 13, 2026
    Sale
    Direct
    2.5K shares at avg. $71.39$179K
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Jul 13, 2026
    Sale
    Direct
    32.7K shares at avg. $71.52$2.3M
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Jul 10, 2026
    Exercise
    Direct
    14.3K shares-
  • Liquidia Corp logo
    LQDA

    Liquidia Corp

    Jul 10, 2026
    Exercise
    Direct
    13.8K shares-
  • Axsome Therapeutics, Inc. logo
    AXSM

    Axsome Therapeutics, Inc.

    Jun 11, 2026
    Sale
    Direct
    286 shares at avg. $249.12$71K
  • Axsome Therapeutics, Inc. logo
    AXSM

    Axsome Therapeutics, Inc.

    Jun 10, 2026
    Sale
    Direct
    286 shares at avg. $246.18$70K
  • Axsome Therapeutics, Inc. logo
    AXSM

    Axsome Therapeutics, Inc.

    Jun 8, 2026
    Exercise
    Direct
    1.4K shares-

1-10 of 59

…